FDA Approves Frontline Immunotherapy for Gastric Cancers
The US Food and Drug Administration (FDA) today approved the immunotherapy nivolumab (Opdivo, Bristol-Myers Squibb) in conjunction with certain chemotherapies …
Home ยป
Mysterious Relief: Vaccines Help Some COVID Long Haulers
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. An estimated 10% to 30% of …
COVID-19 Vaccination in RMD Patients: Safety Data ‘Reassuring’
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Two reports support the safety and …
Ablative Radiation Extends Life in Unresectable Pancreatic Cancer
For patients with inoperable pancreatic cancer, higher dose ablative radiation after chemotherapy induction may extend life, say investigators from Memorial …
Can Supplementary Estrogen Relieve MS Symptoms?
It’s time for a large-scale phase 2 study into whether supplementary estrogen can relieve multiple sclerosis (MS) symptoms in menopausal …
Mitochondrial DNA Variant Increases Gallstone Risk
A mitochondrial DNA variant may increase the risk of gallstone disease more than fourfold, according to investigators. Mitochondrial DNA 827A>G …
Adalimumab Earns FDA Approval for Ulcerative Colitis in Children
Adalimumab has received approval from the Food and Drug Administration for use in pediatric patients aged 5 years and older …
Combo Shows ‘Impressive’ Survival Results in First-Line RCC
The combination of lenvatinib and pembrolizumab outperforms sunitinib as first-line therapy for advanced clear-cell renal cell carcinoma (RCC), based on …
Rituximab Likely Well-Tolerated in Pediatric Patients, but Infections Are Common
NEW YORK (Reuters Health) – Rituximab seemed to be well tolerated in children and adolescents in a retrospective study, but …